![4-[(4-Methylpiperazin-1-yl)methyl]acidi dihydrochloridi benzoici CAS 106261-49-8 Imatinib Mesylate Intermedia High Purity Image](https://www.ruifuchemical.com/uploads/d1fa2a19.jpg)
4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici CAS 106261-49-8 Imatinib Mesylate intermedia High Munditia
Commercial Supple Imatinib Mesylate et intermedia:
Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl) -4-(pyridin-3-yl) pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS:
4-[(4-Methylpiperazin-1-yl) methyl] acidum benzoicum dihydrochloridum CAS: 106261-49-8
| Nomen chemicum | 4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici |
| Synonyma | Imatinib Mesylate media |
| CAS Number | 106261-49-8 |
| CATTUS Number | RF-PI229 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C13H20Cl2N2O2 |
| M. Pondus | 307.22 |
| Liquescens punctum | 305.0~307.0℃ |
| Solubilitas | Solutum in aqua |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | White to Fere Alba pulveris ad Crystal |
| Puritas / Analysis Methodus | ≥98.0% (HPLC) |
| Damnum in Siccatio | ≤0.50% |
| Requiesce in ignitio | ≤0.50% |
| Totalis immunditias | ≤2.0% |
| Maximum Impuritas | ≤1.0% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Pharmaceutical Medium de Imatinib Mesylate (CAS: 220127-57-1) |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica et supplementum 4-[(4-Methylpiperazin-1-yl) methyl] acidum benzoicum dihydrochloridum (CAS: 106261-49-8) cum qualitate alta.Itmedium est typice in synthesi Imatinib Mesylate (CAS: 220127-57-1).Imatinib Mesylate tyrosinum inhibitor kinasus est, valde specificus pro BCR-ABL, medicamentum orale pro curatione aegrorum adultorum cum Philadelphia chromosomatum positivi chronici myeloidei leukemia (CML) in periodo acuta et quibusdam formis lymphoblasticis acuta leukemia (ALL), accelerata. phase et chronica periodus post defectum interferionis justo.
![4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici CAS 106261-49-8 Imatinib Mesylate intermedia High Munditia](https://www.ruifuchemical.com/uploads/d1fa2a19-300x300.jpg)